| Reaction Details |
|---|
 | Report a problem with these data |
| Target | Urokinase-type plasminogen activator [179-431,I214M,N322A,S371A] |
|---|
| Ligand | BDBM14333 |
|---|
| Substrate/Competitor | BDBM14484 |
|---|
| Meas. Tech. | Enzyme Assay and Determination of the Inhibition Constants |
|---|
| Ki | 39000±n/a nM |
|---|
| Citation |  Katz, BA; Luong, C; Ho, JD; Somoza, JR; Gjerstad, E; Tang, J; Williams, SR; Verner, E; Mackman, RL; Young, WB; Sprengeler, PA; Chan, H; Mortara, K; Janc, JW; McGrath, ME Dissecting and designing inhibitor selectivity determinants at the S1 site using an artificial Ala190 protease (Ala190 uPA). J Mol Biol344:527-47 (2004) [PubMed] Article |
|---|
| More Info.: | Get all data from this article, Solution Info, Assay Method |
|---|
| |
| Urokinase-type plasminogen activator [179-431,I214M,N322A,S371A] |
|---|
| Name: | Urokinase-type plasminogen activator [179-431,I214M,N322A,S371A] |
|---|
| Synonyms: | LMW uPA | PLAU | U-plasminogen activator | UROK_HUMAN | Urokinase (uPA) Mutant (S190A) | deglycosylated (N145A) LMW uPA Mutant S190A |
|---|
| Type: | Enzyme |
|---|
| Mol. Mass.: | 28389.65 |
|---|
| Organism: | Homo sapiens (Human) |
|---|
| Description: | Mutagenically deglycosylated (N145A) low molecular mass urokinase (S190A), referred to as Ala190 uPA. |
|---|
| Residue: | 253 |
|---|
| Sequence: | IIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLMSPCWVISATHCFIDYPKKEDYIVY
LGRSRLNSNTQGEMKFEVENLILHKDYSADTLAHHNDIALLKIRSKEGRCAQPSRTIQTI
CLPSMYNDPQFGTSCEITGFGKEASTDYLYPEQLKMTVVKLISHRECQQPHYYGSEVTTK
MLCAADPQWKTDACQGDSGGPLVCSLQGRMTLTGIVSWGRGCALKDKPGVYTRVSHFLPW
IRSHTKEENGLAL
|
|
|
|---|
| BDBM14333 |
|---|
| BDBM14484 |
|---|
| Name | BDBM14333 |
|---|
| Synonyms: | 2-{5-[amino(iminiumyl)methyl]-6-fluoro-1H-1,3-benzodiazol-2-yl}-6-phenylbenzen-1-olate | CA-09 | CRA-10818 |
|---|
| Type | Small organic molecule |
|---|
| Emp. Form. | C20H15FN4O |
|---|
| Mol. Mass. | 346.3577 |
|---|
| SMILES | NC(=[NH2+])c1cc2nc([nH]c2cc1F)-c1cccc(-c2ccccc2)c1[O-] |
|---|
| Structure | 
|
|---|
Search and Browse
